What is Micro-Leads?
Micro-Leads is at the forefront of developing closed-loop neuromodulation platforms designed for high-resolution, minimally-invasive nerve stimulation. Their technological innovations span advanced therapeutic solutions for spinal cord stimulation, peripheral nerve stimulation, and brain-computer interfaces. The company's expertise is evident in its programmable electrodes and sophisticated neurostimulators, all engineered to deliver personalized therapies via closed-loop sensing technology. Micro-Leads primarily serves clients within the medical field, focusing on entities engaged in neuromodulation and the development of therapeutic devices.
How much funding has Micro-Leads raised?
Micro-Leads has raised a total of $10M across 1 funding round:
Other Financing Round
$10M
Other Financing Round (2019): $10M with participation from National Institutes of Health
Key Investors in Micro-Leads
National Institutes of Health
The National Institutes of Health (NIH) is a primary agency of the U.S. Department of Health and Human Services, dedicated to biomedical and health-related research, providing crucial support for scientific advancement in the medical field.
What's next for Micro-Leads?
With this major enterprise-level funding, Micro-Leads is poised for significant expansion and further development of its groundbreaking neuromodulation technologies. The strategic investment signals strong confidence in the company's ability to scale its operations and penetrate deeper into the medical device market. Future endeavors will likely focus on clinical validation, broader market adoption, and continued innovation in personalized therapeutic solutions, solidifying its role as a leader in the field.
See full Micro-Leads company page
